WO2005037239A3 - Use of a compound from the group of heterodiazoles or a salt of said compound, cosmetic or therapeutic formulation containing said compound or salt, said compound or salt as a therapeutic agent, and said salt - Google Patents

Use of a compound from the group of heterodiazoles or a salt of said compound, cosmetic or therapeutic formulation containing said compound or salt, said compound or salt as a therapeutic agent, and said salt Download PDF

Info

Publication number
WO2005037239A3
WO2005037239A3 PCT/EP2004/052544 EP2004052544W WO2005037239A3 WO 2005037239 A3 WO2005037239 A3 WO 2005037239A3 EP 2004052544 W EP2004052544 W EP 2004052544W WO 2005037239 A3 WO2005037239 A3 WO 2005037239A3
Authority
WO
WIPO (PCT)
Prior art keywords
compound
salt
group
heterodiazoles
cosmetic
Prior art date
Application number
PCT/EP2004/052544
Other languages
German (de)
French (fr)
Other versions
WO2005037239A2 (en
Inventor
Gabriele Vielhaber
Karin Jacobs
Original Assignee
Symrise Gmbh & Co Kg
Gabriele Vielhaber
Karin Jacobs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symrise Gmbh & Co Kg, Gabriele Vielhaber, Karin Jacobs filed Critical Symrise Gmbh & Co Kg
Publication of WO2005037239A2 publication Critical patent/WO2005037239A2/en
Publication of WO2005037239A3 publication Critical patent/WO2005037239A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the use of a compound of formula (I) or a salt of said compound of formula (I) for tanning skin and/or hair, among other things, X representing O or S and Ht representing a heterocycle (A) or (B) having structures (A) or (B). Heterocycle (A) or (B) contains two to four N atoms in the ring and is unsubstituted, or heterocycle (A) carries one substituent while heterocycle (B) carries one or two substituents, said substituent/s being independently selected among the group comprising C1-C3 alkoxy, C1-C3 alkylsulfanyl, C1-C10 alkenyl, OH, SH, NH2, C1-C10 alkyl excluding t-butyl.
PCT/EP2004/052544 2003-10-20 2004-10-14 Use of a compound from the group of heterodiazoles or a salt of said compound, cosmetic or therapeutic formulation containing said compound or salt, said compound or salt as a therapeutic agent, and said salt WO2005037239A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2003148554 DE10348554A1 (en) 2003-10-20 2003-10-20 Use of a compound from the group of heterodiazoles or a salt of the compound, the compound or the salt-containing cosmetic or therapeutic formulation, the compound or the salt as a therapeutic agent and the salt itself
DE10348554.6 2003-10-20

Publications (2)

Publication Number Publication Date
WO2005037239A2 WO2005037239A2 (en) 2005-04-28
WO2005037239A3 true WO2005037239A3 (en) 2005-07-28

Family

ID=34442111

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/052544 WO2005037239A2 (en) 2003-10-20 2004-10-14 Use of a compound from the group of heterodiazoles or a salt of said compound, cosmetic or therapeutic formulation containing said compound or salt, said compound or salt as a therapeutic agent, and said salt

Country Status (2)

Country Link
DE (1) DE10348554A1 (en)
WO (1) WO2005037239A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007009281A2 (en) * 2005-07-15 2007-01-25 Andreas Jordi Method for the production of water-based perfumes, and water-based perfume
FR2896687B1 (en) * 2006-01-27 2008-07-18 Oreal PROCESS FOR PREPARING A COSMETIC COMPOSITION AND APPARATUS FOR IMPLEMENTING SUCH A METHOD
FR2896703B1 (en) * 2006-01-27 2008-07-25 Oreal PROCESS FOR PREPARING A COSMETIC COMPOSITION, ASSEMBLY AND RECHARGE FOR IMPLEMENTING SUCH A METHOD
FR2896686B1 (en) * 2006-01-27 2008-09-19 Oreal PROCESS FOR THE PREPARATION OF A COSMETIC COMPOSITION, APPARATUS AND RECHARGE FOR THE PREPARATION OF SUCH A COMPOSITION
DE102006006864A1 (en) * 2006-02-13 2007-08-16 Beiersdorf Ag Cosmetic preparation, useful e.g. to prevent premature skin aging, comprises water-soluble UV-light protective filter, and a copolymer of vinylpyrrolidone and acrylic acid
DE102006009850A1 (en) * 2006-03-01 2007-09-06 Beiersdorf Ag Use of glycyrrhetinic acid and / or glycyrrhizin for the preparation of cosmetic preparations for tanning the skin
DE102007013857A1 (en) 2007-03-20 2008-09-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh New compositions, especially for the topical treatment of skin diseases
DE102010028365A1 (en) 2010-04-29 2011-11-03 Lichtblick Gmbh Use of a phospholipid-containing composition for the removal of subcutaneous fat accumulations
DE102012215520A1 (en) * 2012-08-31 2014-03-06 Beiersdorf Ag Cosmetic or dermatological preparations containing one or more pyridazine derivatives and use of one or more pyridazine derivatives for the preparation of cosmetic preparations for tanning the skin

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861367A (en) * 1987-04-03 1989-08-29 Ciba-Geigy Corporation 2-Mercapto-5-pyrazinyl-1,3,4-oxadiazoles or 2-mercapto-5-pyrazinyl-1,3,4-thiadiazoles as nematicides
US5356898A (en) * 1991-01-31 1994-10-18 Warner-Lambert Company Substituted 4,6-di-tertiary-butyl 5-hydroxy-pyrimidines
US20020031536A1 (en) * 1996-03-22 2002-03-14 L'oreal Sa Cosmetic compositions based on 4,5-pyrazolinediones, novel 4,5-pyrazolinediones, process for their preparation and uses thereof
DE10150412A1 (en) * 2001-10-11 2003-04-17 Beiersdorf Ag Purines or pyrimidines are used in cosmetics or dermatological compositions used in intensifying natural skin tanning or in stimulating melanogenesis in human skin

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861367A (en) * 1987-04-03 1989-08-29 Ciba-Geigy Corporation 2-Mercapto-5-pyrazinyl-1,3,4-oxadiazoles or 2-mercapto-5-pyrazinyl-1,3,4-thiadiazoles as nematicides
US5356898A (en) * 1991-01-31 1994-10-18 Warner-Lambert Company Substituted 4,6-di-tertiary-butyl 5-hydroxy-pyrimidines
US20020031536A1 (en) * 1996-03-22 2002-03-14 L'oreal Sa Cosmetic compositions based on 4,5-pyrazolinediones, novel 4,5-pyrazolinediones, process for their preparation and uses thereof
DE10150412A1 (en) * 2001-10-11 2003-04-17 Beiersdorf Ag Purines or pyrimidines are used in cosmetics or dermatological compositions used in intensifying natural skin tanning or in stimulating melanogenesis in human skin

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ACTA POLONIAE PHARMACEUTICA , 45(5), 373-9 CODEN: APPHAX; ISSN: 0001-6837, 1988 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; GOVINDARAJAN, R. ET AL: "Synthesis of pyrazinyl and related heterocycles as possible antitubercular agents", XP002325819, retrieved from STN Database accession no. 2002:526809 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; PANCECHOWSKA-KSEPKO, DANUTA ET AL: "Pyrazine derivatives. XXV. Synthesis and tuberculostatic activity of the reaction products of 5-(6-methoxy-2-pyrazinyl)- and 5-(6-morpholino-2- pyrazinyl)-1,3,4-oxadiazole-2-thiones with amines", XP002326045, retrieved from STN Database accession no. 1989:497185 *
INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY , 11(4), 337-338 CODEN: IJCHEI; ISSN: 0971-1627, 2002 *
JOURNAL OF PHARMACEUTICAL SCIENCES., vol. 61, no. 9, 1972, USAMERICAN PHARMACEUTICAL ASSOCIATION. WASHINGTON., pages 1483 - 1486, XP002325818 *

Also Published As

Publication number Publication date
WO2005037239A2 (en) 2005-04-28
DE10348554A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
HUP0300393A2 (en) C-aryl glucoside sglt2 inhibitors and their use and pharmaceutical compositions containing them
HUP0002348A2 (en) Cosmetic compositions comprising santalins, santarubins for artificially coloring the skin
WO2007110415A3 (en) Use of diacetyl trimers and cosmetic or therapeutic formulations containing these compounds
MY148437A (en) Pigmentation-regulating compounds
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
EP1689713A4 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease
IL171977A0 (en) Cyclic sulfonamides for inhibition of gamma-secretase
EP1673078A4 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
EA201001669A1 (en) SUBSTITUTED PYRIMIDIN-5-CARBOXAMIDES 281
HUP0401174A2 (en) Ecteinascidin analogues, their use in the preparation of a medicament for treatment of cancer and pharmaceutical compositions containing the compounds
WO2007136116A3 (en) C-phenyl glycitol compound for the treatment of diabetes
MY129023A (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
BRPI0410074A (en) compounds, processes for their preparation and use, composition, and processes for increasing the production of collagen and / or elastin in human skin and / or for retarding or treating skin aging.
ATE389395T1 (en) SUBSTITUTED 2-AMINOTETRALINE FOR THE PREVENTIVE TREATMENT OF PARKINSON'S DISEASE
ATE512147T1 (en) MACROCYCLIC AMINIOPYRIDYL BETA SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
CA2744756A1 (en) Monocarbams and their use as antibacterial agent
PL336581A1 (en) Fungicides
WO2005037239A3 (en) Use of a compound from the group of heterodiazoles or a salt of said compound, cosmetic or therapeutic formulation containing said compound or salt, said compound or salt as a therapeutic agent, and said salt
RU2011112684A (en) AGENT FACILITATING HAIR GROWTH CONTAINING AN ACTIVE INGREDIENT Derivative 15,15-DIFFOROPROSTAGLANDINE F2α
PL348625A1 (en) Compositions containing compounds of flavilyll salt type not-substituted at position 3 for tanning human skin as well as applications of them
EA200901402A1 (en) THERAPEUTICOL AGAINST GLAUCOMA, CONTAINING AS Adenosine Derivative as an Active Ingredient
ATE482933T1 (en) SULFOPYRROL DERIVATIVES
NO20072089L (en) Benzimidazole derivatives, compositions containing them, their preparation and their use
ATE270550T1 (en) ACTIVE SUBSTANCE TO PROTECT ORGANS OR TISSUES

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase